Company intelligence / Profile preview

ACCU-BREAK Generics

Plantation, Florida, USA
Ownership
Private
Development stage
Other
01

Overview

Accu-Break Pharmaceuticals was a specialty pharmaceutical company that developed a proprietary drug delivery platform focused on 'splittable' tablet technology. The company's Accu-Break designs, including Accu-B and Accu-T, allowed tablets to be broken into precise, smaller doses without crumbling, which is particularly useful for medications requiring dose titration. This technology was designed to improve patient compliance and safety by ensuring accurate dosing when a full tablet is not required. Accu-Break primarily operated by licensing its technology to other pharmaceutical companies, such as Aurobindo Pharma, for use in both branded and generic medications. The company's portfolio included applications in cardiovascular health and other therapeutic areas where flexible dosing is critical. Accu-Break Pharmaceuticals and its subsidiary, Accu-Break Generics, are currently inactive, having dissolved their business operations in the mid-2010s.

Therapeutic areas
Cardiovascular
Modalities
Small molecule
Industry
Biotech
02

Partnerships

Aurobindo Pharma

Beyond the preview

Go deeper on ACCU-BREAK Generics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACCU-BREAK Generics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call